References in periodicals archive ?
Should you recommend a proton pump inhibitor (PPI) to decrease the likelihood of a future upper GI bleed?
The use of proton pump inhibitors is associated with anemia in cardiovascular out patients.
The above approval was made based on the results of a double-blind controlled Phase III clinical study conducted in Japan, in which the efficacy and safety of twice-daily dosing of Pariet 10 mg Tablets were evaluated against once-daily dosing of Pariet 10 mg Tablets in patients with reflux esophagitis who had inadequate response to existing treatment with proton pump inhibitors.
Proton pump inhibitors: Are we still prescribing them without valid indications?
This article will make some suggestions about protecting renal function as we age, and what those who suffer gastroesophageal reflux (GERD) should change in light of the disturbing findings about proton pump inhibitors.
Proton pump inhibitors have several long-term consequences that most people have the good sense to want to avoid.
Proton pump inhibitors (PPIs) are the most widely used agents for suppression of gastric acid in patients with nonerosive gastroesophageal reflux disease and erosive esophagitis.
Proton pump inhibitor treatment partially reversed these changes in patients with PPRE but showed no effect for patients with EoE.
Overutilization of proton pump inhibitors: What the clinician needs to know.
Patients with acid reflux and Barrett's esophagus may need to take a proton pump inhibitor (PPI) such as omeprazole twice a day if they are still experiencing symptoms with just a single daily dose.
Recent advances in proton pump inhibitors and management of acid-peptic disorders.